| Marcia Mcgill, MSW | |
|
103 Landmark Dr, Siute 240, Bellevue, KY 41073-1393 | |
| (859) 292-3900 | |
| (859) 292-3903 |
| Full Name | Marcia Mcgill |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 103 Landmark Dr, Bellevue, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457409054 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | KY-976 (Kentucky) | Primary |
| 1041C0700X | Social Worker - Clinical | 0005483 (Ohio) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Marcia Mcgill, MSW 103 Landmark Dr, Siute 240, Bellevue, KY 41073-1393 Ph: (859) 292-3900 | Marcia Mcgill, MSW 103 Landmark Dr, Siute 240, Bellevue, KY 41073-1393 Ph: (859) 292-3900 |
News Archive
In a series about the health care systems in five countries, the NewsHour examines the Netherlands and its massive health care overhaul. "When the Netherlands redesigned its national health care system in 2006, there were three main goals: continue universal coverage, unleash competition between private insurers, and keep down costs for the long run.
CANTEL MEDICAL CORP., through its Crosstex International subsidiary, has further expanded its infection prevention and control business by purchasing the sterilization monitoring business of ConFirm Monitoring Systems, Inc. Based in Denver, Colorado, ConFirm is one of the leading providers of biological monitoring services in North America.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a July 1, 2008 decision by the District Court to grant AstraZeneca's motion for summary judgment of no inequitable conduct related to U.S. Patent No. 4,879,288.
The study showed that bone marrow derived cells can differentiate into functional gastrointestinal epithelial cells after bone marrow transplantation.
Empagliflozin (EMPA), a selective inhibitor of sodium/glucose cotransporter 2 (SGLT2 inhibitors, "gliflozines"), reduces CKD progression in type 2 diabetics (T2D) with cardiovascular disease, presumably by lowering intraglomerular pressure.
› Verified 3 days ago
Nicole R Michaelson, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 103 Landmark Dr, Ste380/cpd, Bellevue, KY 41073 Phone: 859-392-3829 Fax: 859-392-3966 | |
Allyson Lilburn, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 103 Landmark Dr, Bellevue, KY 41073 Phone: 859-392-3844 | |
Bethany Hamilton-clary, LISW-S Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 103 Landmark Dr, Suite 370, Bellevue, KY 41073 Phone: 859-392-3828 | |
Christie Lynn Watson, LISW-S Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 103 Landmark Dr, Suite 370, Bellevue, KY 41073 Phone: 859-392-3828 Fax: 859-392-3966 | |
Robert Matthew Richey, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 103 Landmark Dr, Bellevue, KY 41073 Phone: 859-392-3962 Fax: 859-392-3978 | |
Mr. Michael D Wheeler, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 103 Landmark Dr Ste 370, Bellevue, KY 41073 Phone: 513-568-9070 Fax: 859-392-3966 |